| Biomarker ID | 485 |
| PMID | 20632177 |
| Year | 2010 |
| Biomarker | Methylation Status of GSTP1 or RASSF1A |
| Biomarker Basis | Methylation Based |
| Biomolecule | Methylation |
| Source | Urine |
| Subjects | Humans |
| Regulation | HyperMethylated in PCa |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways include (GSTP1): Biological oxidations, Metapathway biotransformation, Pathways in cancer, T cell receptor regulation of apoptosis, Metabolism |
| Experiment | Prostate Cancer Vs No Tumor |
| Type of Biomarker | Diagnostic |
| Cohort | 115 men were chosen for the study out of which 79 had no tumor and 34 had Prostate Cancer. |
| Senstivity | 53.3% [27.4–77.7] |
| Specificity | 45.9% [29.8–62.49] |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.05 |
| Method Used | Methylation-specific PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | GSTP1: RASSF1 |